CRISPR Therapeutics AG
Long

CRISPR - Bullish - mid-term

190
CRISPR - Bullish - mid-term - Q1/Q2 possible route

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.